It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
But a vaccine with adjuvant can produce a good immune response to viruses that are similar but not exactly the same as the vaccine target. There's also a chance one dose of adjuvanted vaccine would suffice for everyone, even young children. Preliminary data released last week by GlaxoSmithKline - the makers of Canada's H1N1 vaccine - shows even young children got what looks like a protective immune response from one dose of vaccine. Children under 10 are currently slated to get two shots, at least 21 days apart - a regimen that will be a figurative pain for parents and a literal one for kids. But Canada's chief public health officer, Dr. David Butler-Jones, says that recommendation may be revised if further data supports a one-dose approach.
AS03 is newer and isn't in GSK's seasonal flu vaccine. But the company has been testing an AS03-boosted vaccine to protect against H5N1 avian flu and a total of 41,000 people have received AS03 in clinical trials, says Dr. Thomas Breuer, head of global clinical development and chief medical officer of GSK Biologicals. In addition, as of late last week 150,000 people had received GSK's H1N1 vaccine containing AS03. To date, there have been no red flags.
Let's be clear. We're not talking about excruciating pain, we're talking about a bit more of a sore arm than usual - though some years seasonal flu vaccine packs a bit of a wallop too. About the pain: The adjuvant causes some inflammation at the site of the injection, a process that activates parts of the immune system. "Invariably adjuvants give you more pain, swelling," Fauci says. "But as far as prolonged or long-term systemic effects, there have been no good data to indicate (that) at all. In fact, the data to the contrary have shown, that it's really quite safe."
Text
1. Infectious Diseases - A number of infectious agents were present in the Gulf but medical records generally show that they weren't a major problem for personnel due to extensive precautionary measures (1). Of cause many infectious agents may lie dormant without causing an acute illness. The most common infectious agents present were thought to be cutaneous leishmaniasis, travelers diarrhea, sandfly fever and malaria. One unique infectious disease has been linked to the Gulf war deployment: viscerotrophic leishmaniasis (1). This infectious disease has been found in 12 U.S. veterans but none of the other Coalition forces personnel.
There is substantial evidence for mycoplasma infection playing a role in veterans illnesses. Mycoplasma can be defined as the smallest organisms lacking cell walls that are capable of self-replication and can cause various diseases in humans. Although usually associated with respitory and urinary disease, mycoplasma are thought by a growing number of medical professionals to be responsible for a number of unexplained symptoms, especially chronic fatigue states. Mycoplasma fermentans has been found in the blood of gulf war veterans at a much higher rate than in the overall population (2, 3, 4).
Originally posted by marg6043
BTW, please people stop bashing grammar no everybody has a degree in linguistics or have an English major, we are after all people from many parts of the world in ATS.
Originally posted by Amagnon
Originally posted by marg6043
BTW, please people stop bashing grammar no everybody has a degree in linguistics or have an English major, we are after all people from many parts of the world in ATS.
Despite the extremely poor level of grammar on ATS I don't usually complain, its not very productive.
Originally posted by BlubberyConspiracy
Hes saying that the mainstream medias are lying about vaccinations, and stating things as fact, that they are only speculation, or propaganizing if that is even a word.
From wiki.
subsequent investigation revealed that the study in question, which attempted to link squalene to Gulf War Syndrome, had several technical deficiencies in the way in which it analyzed its data. On top of this, it has been determined that the anthrax vaccines given to those US military personnel, did not actually contain added squalene.
Originally posted by marg6043
reply to post by Jigore
I guess the so call expert forgot that the squalene used in the vaccine is not the natural squalene that we humans and animals produce but a man made additive that is not natural at all.
Hell that is why manufacturing of drugs is so cheap while been sold to us so expensive, if the big pharma were using natural ingredients in the crap they manufacture their drugs will priced like gold.
Oil-based vaccination adjuvants like squalene have been proved to generate concentrated, unremitting immune responses over long periods of time.
A 2000 study published in the American Journal of Pathology demonstrated a single injection of the adjuvant squalene into rats triggered “chronic, immune-mediated joint-specific inflammation,” also known as rheumatoid arthritis.
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries.
There are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.
MF-59, MF59TM is a sub-micron oil-in-water emulsion of a squalene, polyoxyethylene sorbitan monooleate (TweenTM 80) and sorbitan trioleate. Squalene is a natural organic compound originally obtained from shark liver oil and a biochemical precursor to steroids. The MF59 adjuvant was developed by Chiron Corp., a company acquired by Novartis. MF59 is approved in Europe and is found in several vaccines, such as an influenza vaccine manufactured by Novartis. It has also been licensed to other companies and is being actively tested in vaccine trials. Exploring Vaccines
Originally posted by marg6043
The compound of the squalene used in vaccines explained,
MF-59, MF59TM is a sub-micron oil-in-water emulsion of a squalene, polyoxyethylene sorbitan monooleate (TweenTM 80) and sorbitan trioleate. Squalene is a natural organic compound originally obtained from shark liver oil and a biochemical precursor to steroids. The MF59 adjuvant was developed by Chiron Corp., a company acquired by Novartis. MF59 is approved in Europe and is found in several vaccines, such as an influenza vaccine manufactured by Novartis. It has also been licensed to other companies and is being actively tested in vaccine trials. Exploring Vaccines
www.whale.to...
Vaccine Ingredients
www.whale.to...